Carotenoids and cardiovascular health.

Cardiovascular disease (CVD) is the main cause of death in Western countries. Nutrition has a significant role in the prevention of many chronic diseases such as CVD, cancers, and degenerative brain diseases. The major risk and protective factors in the diet are well recognized, but interesting new candidates continue to appear. It is well known that a greater intake of fruit and vegetables can help prevent heart diseases and mortality. Because fruit, berries, and vegetables are chemically complex foods, it is difficult to pinpoint any single nutrient that contributes the most to the cardioprotective effects. Several potential components that are found in fruit, berries, and vegetables are probably involved in the protective effects against CVD. Potential beneficial substances include antioxidant vitamins, folate, fiber, and potassium. Antioxidant compounds found in fruit and vegetables, such as vitamin C, carotenoids, and flavonoids, may influence the risk of CVD by preventing the oxidation of cholesterol in arteries. In this review, the role of main dietary carotenoids, ie, lycopene, beta-carotene, alpha-carotene, beta-cryptoxanthin, lutein, and zeaxanthin, in the prevention of heart diseases is discussed. Although it is clear that a higher intake of fruit and vegetables can help prevent the morbidity and mortality associated with heart diseases, more information is needed to ascertain the association between the intake of single nutrients, such as carotenoids, and the risk of CVD. Currently, the consumption of carotenoids in pharmaceutical forms for the treatment or prevention of heart diseases cannot be recommended.

[1]  A. Rao,et al.  Tomato lycopene and low density lipoprotein oxidation: A human dietary intervention study , 1998, Lipids.

[2]  A. Reunanen,et al.  Antioxidant vitamin intake and coronary mortality in a longitudinal population study. , 1994, American journal of epidemiology.

[3]  D. Spiegelman,et al.  Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake. , 2002, The American journal of clinical nutrition.

[4]  V. Böhm,et al.  Intestinal absorption of lycopene from different matrices and interactions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma , 1999, European journal of nutrition.

[5]  J. Mares-Perlman,et al.  Human serum carotenoid concentrations are related to physiologic and lifestyle factors. , 1996, The Journal of nutrition.

[6]  D. Morel,et al.  Dietary supplementation with beta-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein. , 1999, Free radical biology & medicine.

[7]  J. Olson Biological actions of carotenoids. , 1989, The Journal of nutrition.

[8]  W. Stahl,et al.  Lycopene: a biologically important carotenoid for humans? , 1996, Archives of biochemistry and biophysics.

[9]  Rongling Li,et al.  Provitamin A carotenoid intake and carotid artery plaques: the Atherosclerosis Risk in Communities Study. , 1998, The American journal of clinical nutrition.

[10]  D. Townsend,et al.  The role of carotenoids in the prevention of human pathologies. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  G. Omenn,et al.  Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.

[12]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[13]  P. Di Mascio,et al.  Lycopene as the most efficient biological carotenoid singlet oxygen quencher. , 1989, Archives of biochemistry and biophysics.

[14]  C. la Vecchia,et al.  Beta-carotene intake and risk of nonfatal acute myocardial infarction in women , 1997, European Journal of Epidemiology.

[15]  D. Albanes,et al.  Intake of Flavonoids, Carotenoids, Vitamins C and E, and Risk of Stroke in Male Smokers , 2000, Stroke.

[16]  A. Hofman,et al.  Serum carotenoids and atherosclerosis. The Rotterdam Study. , 2000, Atherosclerosis.

[17]  R. Collins,et al.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[18]  A. Nissinen,et al.  Food intake patterns and 25-year mortality from coronary heart disease: Cross-cultural correlations in the Seven Countries Study , 1999, European Journal of Epidemiology.

[19]  A. Hofman,et al.  Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. , 1999, The American journal of clinical nutrition.

[20]  T. G. Truscott,et al.  Carotenoid radical chemistry and antioxidant/pro-oxidant properties. , 2004, Archives of biochemistry and biophysics.

[21]  N. Krinsky Actions of carotenoids in biological systems. , 1993, Annual review of nutrition.

[22]  J. Buring,et al.  Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in men. , 2005, The American journal of clinical nutrition.

[23]  D. L. Morris,et al.  Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. , 1994, JAMA.

[24]  G. Williamson,et al.  A critical assessment of some biomarker approaches linked with dietary intake , 2001, British Journal of Nutrition.

[25]  J. Buring,et al.  Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. , 2004, The American journal of clinical nutrition.

[26]  J. Potter,et al.  Plasma carotenoids as biomarkers of vegetable and fruit intake. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  S. Ripatti,et al.  Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. , 1997, Lancet.

[28]  E. Rimm,et al.  Relation of Consumption of Vitamin E, Vitamin C, and Carotenoids to Risk for Stroke among Men in the United States , 1999, Annals of Internal Medicine.

[29]  W. Stahl,et al.  cis-trans isomers of lycopene and beta-carotene in human serum and tissues. , 1992, Archives of biochemistry and biophysics.

[30]  F. Kok,et al.  Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study , 1993, The Lancet.

[31]  E. Rimm,et al.  Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. , 2004, The American journal of clinical nutrition.

[32]  J. Manson,et al.  Dietary carotenoids and risk of coronary artery disease in women. , 2003, The American journal of clinical nutrition.

[33]  D. Albanes,et al.  Effect of α-tocopherol and β-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study , 2004 .

[34]  T. Lakka,et al.  Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study , 2001, British Journal of Nutrition.

[35]  F. Kok,et al.  Lycopene and myocardial infarction risk in the EURAMIC Study. , 1997, American journal of epidemiology.

[36]  S. Kiechl,et al.  High plasma levels of alpha- and beta-carotene are associated with a lower risk of atherosclerosis: results from the Bruneck study. , 2000, Atherosclerosis.

[37]  J. Erdman,et al.  Bioavailability of all-trans and cis-Isomers of Lycopene , 2002 .

[38]  Tw MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002, The Lancet.

[39]  A. Folsom,et al.  Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[40]  D. Albanes,et al.  Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. , 2004, European heart journal.

[41]  R. Parker,et al.  Carotenoids in human blood and tissues. , 1989, Journal of NutriLife.

[42]  R. Salkeld,et al.  Serum Antioxidants and Myocardial Infarction: Are Low Levels of Carotenoids and α‐ Tocopherol Risk Factors for Myocardial Infarction? , 1994, Circulation.

[43]  A. Dyer,et al.  Dietary vitamin C, beta-carotene and 30-year risk of stroke: results from the Western Electric Study. , 1997, Neuroepidemiology.

[44]  A. Edwards,et al.  Bioavailability of carotenoids in human subjects , 1999, Proceedings of the Nutrition Society.

[45]  J. Salonen,et al.  Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. , 2003, The American journal of clinical nutrition.

[46]  S. Ripatti,et al.  Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction , 1997, The Lancet.

[47]  J. Manson,et al.  Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.

[48]  J M Holden,et al.  Carotenoid content of fruits and vegetables: an evaluation of analytic data. , 1993, Journal of the American Dietetic Association.

[49]  J. Hautvast,et al.  Dietary factors that affect the bioavailability of carotenoids. , 2000, The Journal of nutrition.

[50]  M. Karagas,et al.  Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. , 1997, JAMA.

[51]  G. Rechkemmer,et al.  Moderate intervention with carotenoid-rich vegetable products reduces lipid peroxidation in men. , 2000, The Journal of nutrition.

[52]  W. Willett,et al.  Prospective Study of Plasma Carotenoids and Tocopherols in Relation to Risk of Ischemic Stroke , 2004, Stroke.

[53]  W. Stahl,et al.  cis-trans isomers of lycopene and β-carotene in human serum and tissues , 1992 .

[54]  W. Willett,et al.  Plasma Carotenoids and Tocopherols and Risk of Myocardial Infarction in a Low-Risk Population of US Male Physicians , 2003, Circulation.

[55]  Walter C Willett,et al.  Optimal diets for prevention of coronary heart disease. , 2002, JAMA.

[56]  F. Kok,et al.  Antioxidants in adipose tissue and myocardial infarcation in a Mediterranean area. The EURAMIC study in M laga. , 1997 .

[57]  H. Stähelin,et al.  Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke Basel Prospective Study , 2004, The clinical investigator.

[58]  A. Coats MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[59]  Nea Malila,et al.  Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. , 2003, JAMA.

[60]  D. Morel,et al.  Dietary supplementation with β-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein , 1999 .

[61]  J. Salonen,et al.  Low Plasma Lycopene Concentration Is Associated With Increased Intima-Media Thickness of the Carotid Artery Wall , 2000, Arteriosclerosis, thrombosis, and vascular biology.